Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples.
adherence
compliance
drug attitude
health belief
psychiatric treatment
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
02
2020
accepted:
01
04
2021
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
25
5
2021
Statut:
epublish
Résumé
Although there is accumulating evidence on the potential influencing factors of medication adherence, the knowledge about patients' attitudes and beliefs toward treatment is only partly utilized in adherence-improving strategies. Several internal and external factors determining adherence have been described regarding many chronic somatic diseases but in recent research, insight on psychiatric patients has been exclusively lacking. As a result, there is a scarcity of effective adherence-improving interventions. Identification of any specific differences or similarities between the attitudes toward treatment of psychiatric and non-psychiatric patients would help to support adherent behavior. We recruited 189 participants from four departments of general psychiatry (GEN PSYCH,
Identifiants
pubmed: 34025463
doi: 10.3389/fpsyt.2021.537309
pmc: PMC8132472
doi:
Types de publication
Journal Article
Langues
eng
Pagination
537309Informations de copyright
Copyright © 2021 Pogany and Lazary.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Patient Educ Couns. 2008 Nov;73(2):371-6
pubmed: 18692978
BMC Psychiatry. 2018 Feb 5;18(1):33
pubmed: 29402325
Prev Med. 2017 Jun;99:269-276
pubmed: 28315760
Patient Prefer Adherence. 2019 Apr 10;13:527-536
pubmed: 31040653
Am J Geriatr Psychiatry. 2005 Dec;13(12):1067-76
pubmed: 16319299
Adv Ther. 2005 Jul-Aug;22(4):313-56
pubmed: 16418141
Am J Geriatr Psychiatry. 2005 Jul;13(7):572-80
pubmed: 16009733
Am J Med Sci. 2016 Apr;351(4):387-99
pubmed: 27079345
Hum Psychopharmacol. 2015 Sep;30(5):377-83
pubmed: 26010762
Health Psychol Rev. 2016 Jun;10(2):113-28
pubmed: 25117692
Res Social Adm Pharm. 2018 Nov;14(11):1015-1019
pubmed: 29306720
Res Social Adm Pharm. 2005 Dec;1(4):508-25
pubmed: 17138493
Health Educ Monogr. 1978 Spring;6(2):160-70
pubmed: 689890
Health Psychol Rev. 2016 Dec;10(4):460-477
pubmed: 27556686
N Engl J Med. 2005 Aug 4;353(5):487-97
pubmed: 16079372
Neuropsychopharmacol Hung. 2021 Mar;23(1):221-231
pubmed: 33835044
PLoS One. 2017 Oct 17;12(10):e0186458
pubmed: 29040335
Eur J Cardiovasc Nurs. 2003 Dec;2(4):323
pubmed: 14667488
Eur J Clin Pharmacol. 2007 Nov;63(11):1063-7
pubmed: 17701404
J Health Psychol. 2005 Sep;10(5):677-86
pubmed: 16033789
J Gen Intern Med. 2006 Feb;21(2):146-51
pubmed: 16336620
Psychol Med. 1992 May;22(2):347-52
pubmed: 1615101
Encephale. 2011 May;37 Suppl 1:S11-8
pubmed: 21600328
Front Psychiatry. 2019 Dec 19;10:918
pubmed: 31920764
Health Aff (Millwood). 2012 Aug;31(8):1836-46
pubmed: 22869663
J Psychosom Res. 1999 Dec;47(6):555-67
pubmed: 10661603
J Gen Intern Med. 2012 Mar;27(3):274-9
pubmed: 21671130
BMC Psychiatry. 2014 Nov 21;14:324
pubmed: 25412702
BMC Public Health. 2015 Nov 26;15:1184
pubmed: 26611468
Am J Manag Care. 2007 Nov;13(11):613-8
pubmed: 17988186
Patient Educ Couns. 2006 Feb;60(2):187-93
pubmed: 16253468
Eur J Clin Pharmacol. 2014 Dec;70(12):1423-31
pubmed: 25277162